ANI Pharmaceuticals
ANIP
$65.36
Share price
0.00%
Change (1 day)
73.28%
Change (1 year)
Categories
ANI Pharmaceuticals (ANIP) - Total assets
Total assets on the balance sheet as of December 2023 : $0.90 B
According to ANI Pharmaceuticals's latest financial reports the company's total assets are $0.90 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ANI Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.90 B | 18.99% |
| 2022-12-31 | $0.76 B | -1.49% |
| 2021-12-31 | $0.77 B | 67.31% |
| 2020-12-31 | $0.46 B | 0.96% |
| 2019-12-31 | $0.45 B | 6.08% |
| 2018-12-31 | $0.43 B | 4.48% |
| 2017-12-31 | $0.41 B | 27.65% |
| 2016-12-31 | $0.32 B | 13.18% |
| 2015-12-31 | $0.28 B | 9.9% |
| 2014-12-31 | $0.25 B | 483.28% |
| 2013-12-31 | $44.5 M | 14.78% |
| 2012-12-31 | $38.76 M | -37.85% |
| 2011-12-31 | $62.37 M | 39.34% |
| 2010-12-31 | $44.76 M | 22.86% |
| 2009-12-31 | $36.43 M | 106.1% |
| 2008-12-31 | $17.67 M | -43.41% |
| 2007-12-31 | $31.24 M | 39.65% |
| 2006-12-31 | $22.37 M | 133.65% |
| 2005-12-31 | $9.57 M | -46.29% |
| 2004-12-31 | $17.82 M | 86.37% |
| 2003-12-31 | $9.56 M | 62.68% |
| 2002-12-31 | $5.87 M | 18.09% |
| 2001-12-31 | $4.97 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 10,330.31% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 24,943.73% | 🇺🇸 USA |
 Cardinal Health CAH | $46.57 B | 5,049.48% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $11.39 B | 1,159.74% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | $7.06 M | -99.22% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.46 B | -48.52% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 4,707.38% | 🇮🇱 Israel |
 Royalty Pharma RPRX | $16.38 B | 1,711.31% | 🇬🇧 UK |
 Lannett Company LCI | $0.33 B | -63.00% | 🇺🇸 USA |